Log in
Enquire now
‌

PHI Optics, Inc. SBIR Phase I Award, April 2019

A SBIR Phase I contract was awarded to Phi Optics, Inc. in April, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1681301
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
Phi Optics, Inc.
Phi Optics, Inc.
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
1R43GM133280-010
Award Phase
Phase I0
Award Amount (USD)
225,0000
Date Awarded
April 1, 2019
0
End Date
September 30, 2019
0
Abstract

Project Summary AbstractCurrent methods for measuring optimal growth rates and subsequent efficient production of recombinant proteins in a bioreactor rely on indirect methods that are time consuming and can make the interpretation of observations error proneThis ultimately affects the reproducibility and the validity of bioreactor production in bio pharma marketwasted research efforttime and expenseThis Small Business Innovation Research Phase I project proposes to study the feasibility of developing unique label free markers for cell cycle based on nuclear morphology correlated with refractive index varianceThe measurements will use the Spatial Light Interference MicroscopySLIMtechnique developed at University of Illinois at Urbana ChampaignOnce the feasibility is proven the work will continue for the development of a lab bench optical instrument for performing high throughput label free and cell cycle phase identification and scoring for bioreactor specimens using quantitative label free assays of morphology and cell dynamicsThe instrument will be commercialized into the research and bio pharma market delivery of fasterfold higher throughputand more accurate characterization of protein production in bioreactors Project NarrativePhi Optics proposes to develop an optical instrument for performing real timequantitative highthroughput cell cycle classification and direct growth monitoring using label free quantitative assays of morphology and dynamicsThe instrument will allow novel bioreactor optimization strategies that could circumvent growth rate limitations and optimize feeding

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like PHI Optics, Inc. SBIR Phase I Award, April 2019

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us